Job Lot Release refers to the formal quality decision authorising a specific manufacturing lot or batch of product for distribution or further processing. This release occurs after completion of required testing, documentation review, and confirmation that the batch meets predefined specifications. Lot release ensures that only compliant products reach clinical sites or commercial markets.
The biopharmaceutical industry performs lot release under GMP frameworks with defined roles for quality assurance and qualified personnel. Release testing may include identity, purity, potency, sterility, endotoxin, and stability-related parameters depending on product type. Documentation review includes batch records, deviation reports, change controls, and analytical results. Regulatory requirements vary by region, with some biologics requiring official control authority batch release by national regulatory agencies before product can be distributed. As product complexity increases and supply chains globalise, lot release processes must balance thoroughness with timeliness, ensuring consistent quality while supporting responsive product supply to patients.
Quality & Compliance
Job Lot Release
Job lot release is the formal quality authorisation permitting a manufactured batch to be released after confirming compliance with predefined specifications.
Continue Exploring
Browse over 900 biopharmaceutical terms across biologics, ADCs, cell & gene therapy, CMC, clinical development and manufacturing.
Browse Glossary →